Patent · US Active

Compounds that inhibit TRPV1 and uses thereof

US7767705B2 · kind B2 · utility

1Cited by
19References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2007
Grant dateAug 3, 2010
Priority date
Expiry dateAug 24, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D231/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I)wherein R3, R7, R9 and L are defined in the description are TRPV1 antagonists that exhibit low inhibitory activity against CYP3A4. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.